|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-1-1
|
|
pubmed:abstractText |
Patients with concomitant hepatitis C (HCV) and B (HBV) infection are difficult to treat due to lack of medicines that control these viral infections and the high risk of hepatocellular carcinoma. Currently, there are insufficient data regarding the therapeutic effect of interleukin-2 (IL-2) during chronic viral infection, but this cytokine has shown antineoplastic activity and may have also an antiviral effect.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1791-7530
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5241-4
|
|
pubmed:meshHeading |
pubmed-meshheading:20044643-Adult,
pubmed-meshheading:20044643-Antineoplastic Agents,
pubmed-meshheading:20044643-Carcinoma, Hepatocellular,
pubmed-meshheading:20044643-Dose-Response Relationship, Drug,
pubmed-meshheading:20044643-Hemophilia A,
pubmed-meshheading:20044643-Hepacivirus,
pubmed-meshheading:20044643-Hepatitis B,
pubmed-meshheading:20044643-Hepatitis B virus,
pubmed-meshheading:20044643-Hepatitis C,
pubmed-meshheading:20044643-Humans,
pubmed-meshheading:20044643-Interleukin-2,
pubmed-meshheading:20044643-Liver Cirrhosis,
pubmed-meshheading:20044643-Liver Neoplasms,
pubmed-meshheading:20044643-RNA, Viral,
pubmed-meshheading:20044643-Virus Replication
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report.
|
|
pubmed:affiliation |
Clinic of Gastroenterology, St Ivan Rilski University Hospital, Ivan Geshov Bvd 15, Sofia, Postal Code 1431, Bulgaria. raditomova@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
